Biotin anti-human CD279 (PD-1) Antibody -上海雅吉生物科技有限公司

规格	价格	库存
25µg	￥ 1488	1

Product Details

Verified Reactivity

Human

Reported Reactivity

African Green, Baboon, Chimpanzee, Common Marmoset, Cynomolgus, Rhesus, Squirrel Monkey

Antibody Type

Monoclonal

Host Species

Mouse

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography and conjugated with biotin under optimal conditions.

Concentration

0.5 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: blocking of ligand binding^1-3,?immunohistochemical staining of paraformaldehyde fixed frozen sections¹³, and spatial biology (IBEX)^15,16. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 329911 and 329912). For highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 329926) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin <0.01 EU/?g).

Application References (PubMed link indicates BioLegend citation)

Dorfman DM, et al. 2006 Am. J. Surg. Pathol. 30:802. (FA)
Radziewicz H, et al. 2007. J. Virol. 81:2545. (FA)
Velu V, et al. 2007. J. Virol. 81:5819. (FA)
Zahn RC, et al. 2008. J. Virol. 82:11577. PubMed
Chang WS, et al. 2008. J. Immunol. 181:6707. (FC) PubMed
Nakamoto N, et al. 2009. PLoS Pathog. 5:e1000313. (FA)
Jones RB, et al. 2009. J. Virol. 83:8722. (FC) PubMed
Vojnov L, et al. 2010. J. Virol. 84:753. (FC) PubMed
Radziewicz H, et al. 2010. J. Immunol. 184:2410. (FC) PubMed
Monteriro P, et al. 2011. J. Immunol. 186:4618. PubMed
Conrad J, et al. 2011. J. Immunol. 186:6871. PubMed
Salisch NC, et al. 2010. J. Immunol. 184:476. (Rhesus reactivity)
Li H and Pauza CD. 2015. Eur. J. Immunol. 45:298. (IHC)
Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed

Product Citations

Cho JW, et al. 2021. Nat Commun. 12:6068. PubMed

RRID

AB_2563526 (BioLegend Cat. No. 329933) AB_2563527 (BioLegend Cat. No. 329934)

Antigen Details

Structure: Immunoglobulin superfamily
Distribution: Transiently expressed on CD4^- CD8^- thymocytes; upregulated in thymocytes and splenic T and B lymphocytes; expressed on activated myeloid cells
Ligand/Receptor: B7-H1 (also known as PD-L1) and B7-DC (PD-L2)
Cell Type: B cells, Lymphocytes, T cells, Thymocytes, Tregs
Biology Area: Cancer Biomarkers, Immunology, Inhibitory Molecules
Molecular Family: CD Molecules, Immune Checkpoint Receptors
Gene ID: 5133 View all products for this Gene ID
UniProt: View information about CD279 on UniProt.org

上海细胞库

原代细胞

细胞培养

细胞服务

酶联试剂盒

生化试剂盒

PCR试剂盒

抗体蛋白

试剂耗材

首页 > 抗体蛋白 > 抗体

产品详情

Product Details

Antigen Details

联系我们